A panel of top scientists is urging the Obama administration to bet big on tumor profiling and immunotherapy treatments in its cancer moonshot — two areas that are viewed with great promise, but still face unanswered questions about their ultimate effectiveness.
The panel is also urging the creation of a network to coordinate clinical trials using immunotherapy, the promising new treatment that turns the body’s immune system against the disease.
…
The recommendations are part of a report issued [Sept. 7] by an expert panel advising the White House in its cancer moonshot initiative.
The tumor network would help scientists better identify which treatments work for which cancers in which patients, the panel said. As scientists become more aware of the many different kinds of cancer…and turn increasingly to more personalized treatments, they see the profiling the genetics of individual tumors as crucial.
…
“[Congress] needed to see a plan,” said Jon Retzlaff, who oversees government affairs at the American Association for Cancer Research. “Now it’s something that we can take to Capitol Hill.[“]
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Read full, original post: Top scientists lay out sweeping recommendations for ‘moonshot’ against cancer
